Teva Pharmaceutical Industries (TEVA) Return on Invested Capital (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Return on Invested Capital came in at 0.0% in Q2 2026, little changed YoY from 0.0% in Q2 2025, and down 66.62% on a QoQ basis from 0.01% in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Return on Invested Capital (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Return on Invested Capital data on file, last reported at 0.0% in Q2 2026.
- Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, up 2.0% from the prior year.
- Return on Invested Capital eased to 0.0% in Q2 2026, from 0.01% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q4 2025 to a low of 0.0% in Q4 2022.
- A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2022 — Return on Invested Capital changed 0 bps — and 2025, when it gained 1 bps.
- Tracing TEVA's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then soared by 132 bps to 0.0% in 2023, then sank by 238 bps to 0.0% in 2024, then surged by 1073 bps to 0.01% in 2025, then slumped by 75 bps to 0.0% in 2026.
- The last three Return on Invested Capital figures came in at 0.0% (Q2 2026), 0.01% (Q1 2026), and 0.01% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | 0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.01% |
| Dec 31, 2025 | 0.01% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |